1. bookVolume 26 (2018): Issue 4 (October 2018)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Open Access

Phenotypic and genotypic variations in Candida albicans isolates from Romanian patients

Published Online: 29 Oct 2018
Volume & Issue: Volume 26 (2018) - Issue 4 (October 2018)
Page range: 405 - 413
Received: 07 May 2018
Accepted: 21 Jun 2018
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English

1. Wong SSW, Samaranayake LP, Seneviratne CJ. In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules. Drug Discov Today. 2014 Nov;19(11):1721-0. DOI: 10.1016/j.drudis.2014.06.00910.1016/j.drudis.2014.06.00924952336Search in Google Scholar

2. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007 Jan;20(1):133-3. DOI: 10.1128/CMR.00029-0610.1128/CMR.00029-06179763717223626Open DOISearch in Google Scholar

3. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010;36(1):1-53. DOI: 10.3109/1040841090324144410.3109/1040841090324144420088682Open DOISearch in Google Scholar

4. Kabir MA, Hussain MA, Ahmad Z. Candida albicans: a model organism for studying fungal pathogens. ISRN Microbiol. 2012 Sep 29;2012:538694.10.5402/2012/538694367168523762753Search in Google Scholar

5. Dixon DM, McNeil MM, Cohen ML, Gellin BG, La Montagne JR. Fungal infections: a growing threat. Public Health Rep. 1996 May-Jun;111(3):226–5.Search in Google Scholar

6. Clark TA, Hajjeh RA. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis. 2002 Dec;15(6):569-4. DOI: 10.1097/00001432-200212000-0000310.1097/00001432-200212000-0000312821832Open DOISearch in Google Scholar

7. Ruhnke M, Maschmeyer G. Management of mycoses in patients with hematologic disease and cancer—review of the literature. Eur J Med Res. 2002 May 31;7(5):227-5.Search in Google Scholar

8. Sanita PV, de Oliveira Mima EG, Pavarina AC, Jorge JH, Machado AL, Vergani CE. Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes. Oral Surg Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Nov;116(5):562-9. DOI: 10.1016/j.oooo.2013.07.00210.1016/j.oooo.2013.07.00224055150Open DOISearch in Google Scholar

9. Gow NAR, van de Veardonk FL, Brown AJP, Netea MG. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol. 2011 Dec 12;10(2):112-2. DOI: 10.1038/nrmicro271110.1038/nrmicro2711362416222158429Open DOISearch in Google Scholar

10. Perlin DS. Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management. Drugs. 2014 Sep;74(14):1573-5. DOI: 10.1007/s40265-014-0286-510.1007/s40265-014-0286-5420111325255923Search in Google Scholar

11. Vargas KG, Joly S. Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J Clin Microbiol. 2002 Feb;40(2):341-0. DOI: 10.1128/JCM.40.2.341-350.200210.1128/JCM.40.2.341-350.200215337111825940Search in Google Scholar

12. Vergani CE, Sanitá PV, Mima EGO, Pavarina AC, Machado AL. Oral candidiasis: Conventional and alternative treatment options. In: Contreras F and Fuentes P (eds) Candidiasis: Epidemiology, Symptoms and Treatment Options, 1st edn. Nova Medical, New York, pp 85–115.Search in Google Scholar

13. Molero G, Díez-Orejas R, Navarro-García F, Monteoliva L, Pla J, Gil C, et al. Candida albicans: genetics, dimorphism and pathogenicity. Int Microbiol. 1998 Jun;1(2):95-106.Search in Google Scholar

14. Poradzka A, Jasik M, Karnafel W, Fiedor P. Clinical aspects of fungal infections in diabetes. Acta Pol Pharm. 2013 Jul-Aug;70(4):587-6.Search in Google Scholar

15. Romeo O, Criseo G. Candida africana and its closest relatives. Mycoses 2011 Nov;54(6):475-6. DOI: 10.1111/j.1439-0507.2010.01939.x10.1111/j.1439-0507.2010.01939.x20667001Open DOISearch in Google Scholar

16. McCullough MJ, Clemons KV, Stevens DA. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol. 1999 Feb;37(2):417-1.10.1128/JCM.37.2.417-421.1999843259889231Search in Google Scholar

17. Li W, Yu D, Gao S, Lin J, Chen Z, Zhao W. Role of Candida albicans secreted aspartyl proteinases (Saps) in severe early childhood caries. Int J Mol Sci. 2014 Jun 13;15(6):10766-9. DOI: 10.3390/ijms15061076610.3390/ijms150610766410017924933640Open DOISearch in Google Scholar

18. Tamura M, Watanabe K, Mikami J, Yazawa K, Nishimura K. Molecular characterization of new chemical isolates of Candida albicans and Candida dubliniensis in Japan. Analysis reveals a new genotype of Candida albicans with Group I Intron. J Clin Microbiol. 2001 Dec;39(12):4309-5. DOI: 10.1128/JCM.39.12.4309-4315.200110.1128/JCM.39.12.4309-4315.20018854111724837Open DOISearch in Google Scholar

19. She XD, Wang XJ, Fu MH, Shen YN, Liu WD. Genotype comparisons of strains of Candida albicans from patients with cutaneous candidiasis and vaginal candidiasis. Chin Med J (Engl). 2008 Aug 5;121(15):1450-5.10.1097/00029330-200808010-00021Search in Google Scholar

20. McCreight MC, Warnock DW. Enhanced differentiation of isolates of Candida albicans using a modified rezistogram method. Mykosen 1982 Nov;25(11):589-8. DOI: 10.1111/j.1439-0507.1982.tb01926.x10.1111/j.1439-0507.1982.tb01926.x6294514Search in Google Scholar

21. Nakamura K, Ito-Kuwa S, Nakamura Y, Aoki S, Vidotto V, Sinicco A. Resistogram typing of the oral Candida albicans isolates from normal subjects in three successive trials. Rev Iberoam Micol. 1998 Mar;15(1):19-1.Search in Google Scholar

22. Prince MF, Wilkinson ID, Gentry LO. Plate methods for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982 Mar;20(1):7-14. DOI: 10.1080/0036217828538003110.1080/003621782853800317038928Open DOISearch in Google Scholar

23. Rasband WS. Image Processing and Analysis in Java (Image J), U.S. National Institutes of Health, Bethesda, Maryland USA, http://imagej.nih.gov/ij. Accessed 17 November 2017.Search in Google Scholar

24. Manns JM, Mosser DM, Buckley HR. Production of a haemolytic factor by Candida albicans. Infect Immun. 1994 Nov;62(11):5154–6.10.1128/iai.62.11.5154-5156.19943032387927798Search in Google Scholar

25. Luo G, Samarannayake LP, You JYY. Candida species exhibit differential in vitro haemolytic activities. J Clin Microbiol. 2001 Aug;39(8):2971–4. DOI: 10.1128/JCM.39.8.2971-2974.200110.1128/JCM.39.8.2971-2974.20018827211474025Search in Google Scholar

26. Barros LM, Boriollo MP, Alves AC, Klein MI, Gonçalves RB, Höfling JF. Genetic diversity and exo-enzyme activity of Candida albicans and Candida dubliniensis isolated from the oral cavity of Brazilian periodontal patients. Arch Oral Biol. 2008 Dec;53(12):1172-8. DOI: 10.1016/j.archoralbio.2008.06.00310.1016/j.archoralbio.2008.06.00318672229Search in Google Scholar

27. Pierce CG, Uppuluri P, Tristan AR, Wormley FL Jr, Mowat E, Ramage G, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3(9):1494-0. DOI: 10.1038/nprot.2008.14110.1038/nprot.2008.141Search in Google Scholar

28. Al-Karaawi ZM, Manfredi M, Waugh ACW, McCullough MJ, Jorge J, Scully C, et al. Characterization of Candida spp. isolated from the oral cavities of patients from diverse clinical settings. Oral Microbiol Immunol. 2002 Feb;17(1):44-9. DOI: 10.1046/j.0902-0055.2001.00081.x10.1046/j.0902-0055.2001.00081.x11860555Open DOISearch in Google Scholar

29. Sugita T, Kurosaka S, Yajitate M, Sato H, Nishikawa A. Extracellular proteinase and phospholipase activity of three genotypic strains of a human pathogenic yeast Candida albicans. Microbiol Immunol. 2002;46(12):881-3. DOI: 10.1111/j.1348-0421.2002.tb02776.x10.1111/j.1348-0421.2002.tb02776.x12597363Open DOISearch in Google Scholar

30. Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell PM, Lamey PJ. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Mar;91(3):317-1. DOI: 10.1067/moe.2001.11215510.1067/moe.2001.11215511250629Open DOISearch in Google Scholar

31. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev. 2000 Jan;13(1):122-3. DOI: 10.1128/CMR.13.1.122-143.200010.1128/CMR.13.1.122-143.2000Open DOISearch in Google Scholar

32. Hannula J, Saarela M, Dogan B, Paatsama J, Koukila-Kähkölä P, Pirinen S, et al. Comparison of virulence factors of oral Candida dubliniensis and Candida albicans isolates in healthy people and patients with chronic candidosis. Oral Microbiol Immunol. 2000 Aug;15(4):238-4. DOI: 10.1034/j.1399-302x.2000.150405.x10.1034/j.1399-302x.2000.150405.x11154409Open DOISearch in Google Scholar

33. Vidotto V, Koga-Ito CY, Milano R, Fianchino B, Poton J. Correlation between germ tube production, phospholipase activity and serotype distribuition in Candida albicans. Rev Iberoam Micol. 1999 Dec;16(4):208-0.Search in Google Scholar

34. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003 Sep;67(3):400-8. DOI: 10.1128/MMBR.67.3.400-428.200310.1128/MMBR.67.3.400-428.200319387312966142Search in Google Scholar

35. Watanabe T, Takano M, Murakami M, Tanaka H, Matsuhisa A, Nakao N, et al. Characterization of a haemolytic factor from Candida albicans. Microbiology. 1999 Mar;145(Pt 3):689-4. DOI: 10.1099/13500872-145-3-68910.1099/13500872-145-3-68910217503Open DOISearch in Google Scholar

36. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. Our current understanding of fungal biofilms. Crit Rev Microbiol. 2009;35(4):340-5. DOI: 10.3109/1040841090324143610.3109/1040841090324143619863383Open DOISearch in Google Scholar

37. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004 Apr;17(2):255–7. DOI: 10.1128/CMR.17.2.255-267.200410.1128/CMR.17.2.255-267.200438740715084500Open DOISearch in Google Scholar

38. Ramage G, Rajendran R, Sherry L, Williams C. Fungal biofilm resistance. Int J Microbiol. 2012;2012:528521. DOI: 10.1155/2012/52852110.1155/2012/528521329932722518145Search in Google Scholar

39. Sherry L, Rajendran R., Lappin D.F, Borghi E, Perdoni F, Falleni M, et al. Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity. BMC Microbiol. 2014;14:182-6. DOI: 10.1186/1471-2180-14-18210.1186/1471-2180-14-182410554724996549Open DOISearch in Google Scholar

40. Pierce CG, Srinivasan A, Uppuluri P, Ramasubramanian AK, Lopez-Ribot JL (2013) Antifungal therapy with an emphasis on biofilms. Curr Opin Pharmacol. 2013 Oct;13(5):726–0. DOI: 10.1016/j.coph.2013.08.00810.1016/j.coph.2013.08.008379593424011516Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo